Income Statement Zhuhai Rundu Pharmaceutical Co., Ltd.

Stocks

002923

CNE1000033G8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-06-18			5-day change	1st Jan Change
9.780 ^CNY	-0.20%		-2.88%	-19.51%

05-22	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT
05-19	China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug	MT

b48306a9419b01.DbgWYcHuYnVp8x6lIJun005GSYXNO7OVRE7RCST8nvc.d_dbNfaKNz0mw3_9UKKKnjsqDdyqVcrkPD2CbE6G-cc43kEw87wQHi3FSw

Published financial data: ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.25B	1.19B	1.36B	1.28B	1.18B
Other Revenues, Total	6.07M	1.98M	9.01M	10.06M	5.53M
Total Revenues	1.25B	1.19B	1.37B	1.29B	1.18B
Cost of Goods Sold, Total	483M	479M	636M	685M	692M
Gross Profit	770M	711M	736M	607M	490M
Selling General & Admin Expenses, Total	529M	476M	460M	393M	310M
Provision for Bad Debts	-677K	487K	2.56M	-728K	139K
R&D Expenses	102M	84.27M	92.34M	127M	129M
Other Operating Expenses	11.8M	12M	15.25M	15.46M	11.27M
Other Operating Expenses, Total	642M	573M	570M	535M	451M
Operating Income	127M	138M	166M	72.31M	39.52M
Interest Expense, Total	-1.77M	-1.77M	-6.97M	-16.12M	-15.78M
Interest And Investment Income	6.13M	2.33M	1.48M	2.25M	1.33M
Net Interest Expenses	4.36M	559K	-5.49M	-13.86M	-14.45M
Currency Exchange Gains (Loss)	-3.03M	-1.34M	1.3M	1.76M	2.85M
Other Non Operating Income (Expenses)	-1.31M	-860K	-453K	-1.12M	-1.94M
EBT, Excl. Unusual Items	127M	137M	161M	59.09M	25.98M
Gain (Loss) On Sale Of Investments	11K	-18.02K	-24.99K	-364K	13.48K
Gain (Loss) On Sale Of Assets	-	-	46.8K	152K	18.02M
Asset Writedown	-2.29M	-228K	-326K	-148K	-433K
Insurance Settlements	-	-	-	-	-
Other Unusual Items	23.78M	15.14M	19.86M	27.31M	-955K
EBT, Incl. Unusual Items	149M	152M	181M	86.04M	42.63M
Income Tax Expense	12.97M	11.97M	25.46M	19.14M	2.74M
Earnings From Continuing Operations	136M	140M	155M	66.9M	39.88M
Net Income to Company	136M	140M	155M	66.9M	39.88M
Net Income - (IS)	136M	140M	155M	66.9M	39.88M
Net Income to Common Incl Extra Items	136M	140M	155M	66.9M	39.88M
Net Income to Common Excl. Extra Items	136M	140M	155M	66.9M	39.88M
Per Share Items
Net EPS - Basic	0.41	0.42	0.46	0.2	0.12
Basic EPS - Continuing Operations	0.41	0.42	0.46	0.2	0.12
Basic Weighted Average Shares Outstanding	334M	335M	335M	334M	332M
Net EPS - Diluted	0.41	0.42	0.46	0.2	0.12
Diluted EPS - Continuing Operations	0.41	0.42	0.46	0.2	0.12
Diluted Weighted Average Shares Outstanding	334M	335M	335M	334M	332M
Normalized Basic EPS	0.24	0.26	0.3	0.11	0.05
Normalized Diluted EPS	0.24	0.26	0.3	0.11	0.05
Dividend Per Share	0.22	0.22	0.25	0.2	0.15
Payout Ratio	56.19	59.13	57.68	153.04	212.36
Supplemental Items
EBITDA	177M	198M	235M	183M	173M
EBITA	129M	140M	168M	73.88M	41.15M
EBIT	127M	138M	166M	72.31M	39.52M
EBITDAR	179M	200M	237M	188M	178M
Total Revenues (As Reported)	1.25B	1.19B	1.37B	1.29B	1.18B
Effective Tax Rate - (Ratio)	8.71	7.89	14.07	22.25	6.44
Current Domestic Taxes	15.27M	8.94M	27.08M	17.28M	3M
Total Current Taxes	15.27M	8.94M	27.08M	17.28M	3M
Deferred Domestic Taxes	-2.3M	3.03M	-1.62M	1.87M	-260K
Total Deferred Taxes	-2.3M	3.03M	-1.62M	1.87M	-260K
Normalized Net Income	79.58M	85.53M	101M	36.93M	16.24M
Interest Capitalized	-	6.14M	9.5M	-	3.06M
Interest on Long-Term Debt	-	-	-	159K	383K
Non-Cash Pension Expense	-	-	-	357K	1.88M
Supplemental Operating Expense Items
Marketing Expenses	-	-	334M	255M	193M
Selling and Marketing Expenses	441M	417M	390M	315M	246M
General and Administrative Expenses	87.73M	59.19M	70.19M	77.88M	64.5M
Research And Development Expense From Footnotes	102M	92.14M	95.59M	129M	131M
Net Rental Expense, Total	1.31M	1.54M	1.56M	4.55M	4.56M
Imputed Operating Lease Interest Expense	376K	548K	545K	1.13M	1.28M
Imputed Operating Lease Depreciation	937K	994K	1.02M	3.42M	3.28M
Maintenance & Repair Expenses, Total	15.52M	16.15M	5.65M	3.4M	4.76M
Stock-Based Comp., G&A Exp. (Total)	18.94M	-6.7M	-	-	-
Total Stock-Based Compensation	18.94M	-6.7M	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	252M	250M	221M	214M	207M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	44.01M	86.77K	61.78K	52.23K	65.71K
Total Cash And Short Term Investments	296M	250M	221M	214M	207M
Accounts Receivable, Total	159M	160M	202M	212M	213M
Other Receivables	3.94M	3.09M	61.37M	3.95M	4.92M
Total Receivables	163M	163M	264M	216M	218M
Inventory	302M	336M	441M	415M	442M
Other Current Assets, Total	17.58M	59.13M	20.62M	21.3M	18.83M
Total Current Assets	778M	808M	946M	867M	886M
Gross Property Plant And Equipment	786M	1.23B	1.55B	1.68B	1.77B
Accumulated Depreciation	-204M	-262M	-330M	-432M	-563M
Net Property Plant And Equipment	582M	973M	1.22B	1.25B	1.21B
Long-term Investments	500K	500K	500K	500K	-
Other Intangibles, Total	65.47M	69M	67.62M	66.05M	64.42M
Deferred Tax Assets Long-Term	11.64M	8.61M	10.23M	10.67M	10.35M
Deferred Charges Long-Term	14.89M	13.31M	12.81M	19.93M	13.66M
Other Long-Term Assets, Total	61.48M	37.31M	25.23M	14.27M	10.55M
Total Assets	1.51B	1.91B	2.29B	2.23B	2.19B
Liabilities
Accounts Payable, Total	91.34M	152M	213M	154M	223M
Accrued Expenses, Total	139M	164M	178M	116M	112M
Short-term Borrowings	58.03M	33M	62.94M	60.54M	25.04M
Current Portion of Long-Term Debt	9.12M	-	25.28M	68.82M	106M
Current Portion of Leases	-	2.52M	1.75M	2.11M	2.22M
Current Income Taxes Payable	2.24M	137K	11.47M	2.26M	-
Unearned Revenue Current, Total	13M	14.29M	46.68M	10.89M	12.46M
Other Current Liabilities	48.11M	56.11M	50.11M	31.93M	42.65M
Total Current Liabilities	361M	423M	590M	446M	524M
Long-Term Debt	2.23M	250M	377M	434M	362M
Long-Term Leases	-	1.08M	975K	7.48M	5.56M
Unearned Revenue Non Current	109M	120M	121M	158M	147M
Deferred Tax Liability Non Current	-	-	-	2.31M	1.73M
Other Non Current Liabilities	3.32M	3.6M	1.18M	1.07M	1.89M
Total Liabilities	476M	797M	1.09B	1.05B	1.04B
Common Stock, Total	186M	186M	239M	335M	335M
Additional Paid In Capital	354M	346M	279M	183M	183M
Retained Earnings	528M	594M	678M	661M	634M
Treasury Stock	-30.52M	-13.86M	-	-	-
Comprehensive Income and Other	-	-	-	-55	380
Total Common Equity	1.04B	1.11B	1.2B	1.18B	1.15B
Total Equity	1.04B	1.11B	1.2B	1.18B	1.15B
Total Liabilities And Equity	1.51B	1.91B	2.29B	2.23B	2.19B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	338M	338M	335M	335M	335M
ECS Total Common Shares Outstanding	338M	338M	335M	335M	335M
Book Value / Share	3.07	3.29	3.57	3.52	3.44
Tangible Book Value	973M	1.04B	1.13B	1.11B	1.09B
Tangible Book Value Per Share	2.87	3.09	3.37	3.32	3.25
Total Debt	69.38M	287M	468M	573M	501M
Net Debt	-226M	36.22M	247M	359M	294M
Debt Equivalent Oper. Leases	10.51M	12.34M	12.49M	36.37M	36.49M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	76.75M	63.76M	119M	112M	69.64M
Inventories - Work In Process, Total	70M	107M	128M	94.17M	67.61M
Inventories - Finished Goods, Total	162M	174M	232M	270M	349M
Buildings, Total	215M	259M	400M	496M	527M
Machinery, Total	478M	518M	849M	967M	1.17B
Full Time Employees	1.48K	1.59K	1.89K	1.94K	1.98K
Accumulated Allowance for Doubtful Accounts (Supple)	6.87M	7.26M	8.67M	8.13M	7.94M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	136M	140M	155M	66.9M	39.88M
Depreciation & Amortization - CF	48.66M	62.16M	70.67M	111M	135M
Amortization of Goodwill and Intangible Assets - (CF)	1.31M	1.54M	1.56M	1.56M	1.63M
Depreciation & Amortization, Total	49.98M	63.7M	72.23M	113M	137M
Amortization of Deferred Charges, Total - (CF)	11.28M	8.96M	5.85M	4.66M	6.1M
(Gain) Loss From Sale Of Asset	-	-	-46.8K	-152K	-
(Gain) Loss on Sale of Investments - (CF)	-3.65M	-407K	-101K	364K	-94.57K
Asset Writedown & Restructuring Costs	2.29M	228K	326K	148K	433K
Provision and Write-off of Bad Debts	-677K	487K	2.56M	-728K	139K
Other Operating Activities, Total	10.77M	6.17M	36.84M	59.4M	29.82M
Change In Accounts Receivable	33.65M	-239M	-53.67M	-11.95M	27.13M
Change In Inventories	-68.96M	-37.38M	-133M	20.92M	-9.53M
Change In Accounts Payable	63.16M	267M	49.69M	-81.62M	-18.97M
Change In Deferred Taxes	-2.3M	3.03M	-1.62M	1.87M	-260K
Change in Other Net Operating Assets	18.94M	-6.7M	-	-	-
Cash from Operations	250M	206M	135M	173M	211M
Capital Expenditure	-257M	-376M	-252M	-175M	-81.25M
Sale of Property, Plant, and Equipment	-	-	70K	-	-
Investment in Marketable and Equity Securities, Total	93.64M	44.43M	126K	-	-1
Other Investing Activities, Total	-	-	-	-	81.1K
Cash from Investing	-163M	-332M	-252M	-175M	-81.17M
Long-Term Debt Issued, Total	58.03M	286M	234M	193M	53.89M
Total Debt Issued	58.03M	286M	234M	193M	53.89M
Long-Term Debt Repaid, Total	-17.96M	-76.33M	-57.69M	-90.36M	-127M
Total Debt Repaid	-17.96M	-76.33M	-57.69M	-90.36M	-127M
Issuance of Common Stock	4.66M	-	-	-	-
Repurchase of Common Stock	-	-1.66M	-13.86M	-	-
Common Dividends Paid	-76.34M	-82.65M	-89.68M	-102M	-84.7M
Common & Preferred Stock Dividends Paid	-76.34M	-82.65M	-89.68M	-102M	-84.7M
Other Financing Activities, Total	-26.87M	29.65M	-	-5.17M	0
Cash from Financing	-58.48M	155M	73.2M	-4.48M	-158M
Foreign Exchange Rate Adjustments	-1.55M	-590K	1.37M	404K	2.43M
Net Change in Cash	27.21M	28.27M	-41.98M	-5.93M	-25.3M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	83.79M	76.66M	81.25M	40.08M	77.33M
Levered Free Cash Flow	-113M	-207M	-129M	-134M	126M
Unlevered Free Cash Flow	-112M	-206M	-125M	-124M	136M
Change In Net Working Capital	14.87M	-18.06M	54.97M	113M	-49.66M
Net Debt Issued / Repaid	40.07M	210M	177M	103M	-73.05M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.6	5.06	4.95	2	1.12
Return on Total Capital	7.66	6.91	6.77	2.65	1.45
Return On Equity %	13.73	13	13.47	5.63	3.42
Return on Common Equity	13.73	13	13.47	5.63	3.42
Margin Analysis
Gross Profit Margin %	61.44	59.76	53.63	46.97	41.48
SG&A Margin	42.21	39.99	33.5	30.38	26.25
EBITDA Margin %	14.15	16.67	17.16	14.18	14.66
EBITA Margin %	10.27	11.77	12.21	5.72	3.48
EBIT Margin %	10.16	11.64	12.1	5.6	3.34
Income From Continuing Operations Margin %	10.85	11.75	11.33	5.18	3.37
Net Income Margin %	10.85	11.75	11.33	5.18	3.37
Net Avail. For Common Margin %	10.85	11.75	11.33	5.18	3.37
Normalized Net Income Margin	6.35	7.19	7.35	2.86	1.37
Levered Free Cash Flow Margin	-9.02	-17.4	-9.42	-10.41	10.65
Unlevered Free Cash Flow Margin	-8.93	-17.31	-9.1	-9.63	11.48
Asset Turnover
Asset Turnover	0.88	0.7	0.65	0.57	0.53
Fixed Assets Turnover	2.45	1.53	1.25	1.04	0.96
Receivables Turnover (Average Receivables)	7.16	7.46	7.53	6.19	5.53
Inventory Turnover (Average Inventory)	1.78	1.5	1.64	1.6	1.61
Short Term Liquidity
Current Ratio	2.16	1.91	1.6	1.94	1.69
Quick Ratio	1.27	0.98	0.82	0.96	0.81
Operating Cash Flow to Current Liabilities	0.69	0.49	0.23	0.39	0.4
Days Sales Outstanding (Average Receivables)	51.12	48.94	48.5	59	66.17
Days Outstanding Inventory (Average Inventory)	205.22	242.98	222.67	228.13	226.79
Average Days Payable Outstanding	46.15	86.85	90.04	101.6	96.07
Cash Conversion Cycle (Average Days)	210.19	205.07	181.13	185.54	196.9
Long Term Solvency
Total Debt/Equity	6.68	25.77	39.17	48.58	43.45
Total Debt / Total Capital	6.26	20.49	28.14	32.7	30.29
LT Debt/Equity	0.21	22.58	31.64	37.43	31.87
Long-Term Debt / Total Capital	0.2	17.95	22.74	25.19	22.22
Total Liabilities / Total Assets	31.41	41.75	47.69	47.07	47.48
EBIT / Interest Expense	71.92	78.15	23.83	4.49	2.5
EBITDA / Interest Expense	100.15	114.1	34.2	11.49	11.16
(EBITDA - Capex) / Interest Expense	-44.88	-98.36	-1.94	0.66	6.01
Total Debt / EBITDA	0.39	1.42	1.97	3.09	2.84
Net Debt / EBITDA	-1.28	0.18	1.04	1.94	1.67
Total Debt / (EBITDA - Capex)	-0.87	-1.64	-34.68	53.81	5.28
Net Debt / (EBITDA - Capex)	2.85	-0.21	-18.31	33.71	3.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.89	-5.01	15.32	-5.86	-8.48
Gross Profit, 1 Yr. Growth %	-20.69	-6.54	3.49	-17.54	-19.18
EBITDA, 1 Yr. Growth %	30.45	-2.52	18.68	-22.2	-4.93
EBITA, 1 Yr. Growth %	29.61	-9.58	19.68	-55.92	-43.62
EBIT, 1 Yr. Growth %	29.51	-9.81	19.88	-56.44	-44.67
Earnings From Cont. Operations, 1 Yr. Growth %	14.27	2.87	11.24	-56.97	-40.38
Net Income, 1 Yr. Growth %	14.27	2.87	11.24	-56.97	-40.38
Normalized Net Income, 1 Yr. Growth %	20.26	-9.44	17.93	-63.39	-55.9
Diluted EPS Before Extra, 1 Yr. Growth %	15.64	2.71	12.07	-56.52	-40
Accounts Receivable, 1 Yr. Growth %	-16.38	0.9	26.44	4.84	0.61
Inventory, 1 Yr. Growth %	26.02	11.1	31.39	-5.76	6.39
Net Property, Plant and Equip., 1 Yr. Growth %	32.14	67.11	25.82	2.12	-3.26
Total Assets, 1 Yr. Growth %	14.1	26.14	19.74	-2.59	-1.53
Tangible Book Value, 1 Yr. Growth %	9.28	7.24	8.17	-1.35	-2.28
Common Equity, 1 Yr. Growth %	10.42	7.12	7.54	-1.41	-2.29
Cash From Operations, 1 Yr. Growth %	65.46	-17.75	-34.43	27.9	22.3
Capital Expenditures, 1 Yr. Growth %	6.97	46.64	-33.13	-30.67	-53.45
Levered Free Cash Flow, 1 Yr. Growth %	13.09	114.42	-37.57	4.06	-193.22
Unlevered Free Cash Flow, 1 Yr. Growth %	13.39	115.74	-39.35	-0.38	-208.62
Dividend Per Share, 1 Yr. Growth %	0	0	13.74	-20	-25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.54	-6.46	4.67	4.2	-7.18
Gross Profit, 2 Yr. CAGR %	-0.82	-14.4	-1.65	-7.62	-18.36
EBITDA, 2 Yr. CAGR %	11.32	20.82	7.56	-3.91	-14.21
EBITA, 2 Yr. CAGR %	7.06	18.78	4.02	-27.37	-50.45
EBIT, 2 Yr. CAGR %	6.78	18.69	3.98	-27.74	-51.21
Earnings From Cont. Operations, 2 Yr. CAGR %	12.76	8.42	6.98	-30.82	-49.35
Net Income, 2 Yr. CAGR %	12.76	8.42	6.98	-30.82	-49.35
Normalized Net Income, 2 Yr. CAGR %	2.75	13.69	3.34	-34.29	-59.88
Diluted EPS Before Extra, 2 Yr. CAGR %	11.99	8.98	6.86	-30.52	-48.92
Accounts Receivable, 2 Yr. CAGR %	10.83	-8.14	12.95	15.14	2.71
Inventory, 2 Yr. CAGR %	32.85	18.32	20.82	11.28	0.13
Net Property, Plant and Equip., 2 Yr. CAGR %	37.16	48.6	45	13.35	-0.61
Total Assets, 2 Yr. CAGR %	15.31	19.97	22.9	8.01	-2.06
Tangible Book Value, 2 Yr. CAGR %	7.07	8.25	7.7	3.3	-1.82
Common Equity, 2 Yr. CAGR %	9.16	8.76	7.33	2.97	-1.85
Cash From Operations, 2 Yr. CAGR %	25.46	16.66	-26.56	-8.42	25.07
Capital Expenditures, 2 Yr. CAGR %	49.22	25.24	-0.98	-31.91	-43.19
Levered Free Cash Flow, 2 Yr. CAGR %	93.91	43.97	15.7	-19.4	-1.31
Unlevered Free Cash Flow, 2 Yr. CAGR %	99.49	44.49	14.39	-22.27	4.26
Dividend Per Share, 2 Yr. CAGR %	0	0	6.65	-4.61	-22.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	17.13	4.46	0.3	1.03	-0.21
Gross Profit, 3 Yr. CAGR %	15.18	-3.13	-8.81	-7.26	-11.65
EBITDA, 3 Yr. CAGR %	10.72	11.51	20.1	-3.45	-4.41
EBITA, 3 Yr. CAGR %	8.53	7.66	19.08	-21.86	-33.52
EBIT, 3 Yr. CAGR %	8.36	7.44	19.09	-22.2	-34.16
Earnings From Cont. Operations, 3 Yr. CAGR %	14.44	9.37	9.35	-21.03	-34.16
Net Income, 3 Yr. CAGR %	14.44	9.37	9.35	-21.03	-34.16
Normalized Net Income, 3 Yr. CAGR %	11.15	4.3	15.08	-26.87	-42.53
Diluted EPS Before Extra, 3 Yr. CAGR %	3.19	8.81	9.71	-21.06	-33.84
Accounts Receivable, 3 Yr. CAGR %	15.83	7.42	2.18	10.18	10.08
Inventory, 3 Yr. CAGR %	34.97	25.16	22.53	11.22	9.62
Net Property, Plant and Equip., 3 Yr. CAGR %	32.81	46.49	40.58	29.01	7.52
Total Assets, 3 Yr. CAGR %	28.95	18.81	19.89	13.75	4.73
Tangible Book Value, 3 Yr. CAGR %	27.84	7.12	8.22	4.59	1.4
Common Equity, 3 Yr. CAGR %	28.54	8.48	8.35	4.33	1.18
Cash From Operations, 3 Yr. CAGR %	40.84	8.99	-3.73	-11.64	0.85
Capital Expenditures, 3 Yr. CAGR %	91.78	48.35	1.6	-12.07	-40.02
Levered Free Cash Flow, 3 Yr. CAGR %	147.31	90.3	8.97	11.68	-15.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	196.95	94.23	8.18	9.24	-12.97
Dividend Per Share, 3 Yr. CAGR %	0.94	0	4.38	-3.1	-11.96
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.73	12.79	11.98	4.36	-2.76
Gross Profit, 5 Yr. CAGR %	14.96	11.28	7.88	-4.95	-12.76
EBITDA, 5 Yr. CAGR %	16.48	12.83	12.5	5.07	4.98
EBITA, 5 Yr. CAGR %	9.55	9.47	10.74	-8.02	-16.14
EBIT, 5 Yr. CAGR %	9.32	9.37	10.66	-8.32	-16.66
Earnings From Cont. Operations, 5 Yr. CAGR %	13.81	9.83	11.39	-8.94	-19.62
Net Income, 5 Yr. CAGR %	13.81	9.83	11.39	-8.94	-19.62
Normalized Net Income, 5 Yr. CAGR %	9.9	9.81	11.72	-13.3	-24.5
Diluted EPS Before Extra, 5 Yr. CAGR %	6.99	3.18	4.65	-9.21	-19.35
Accounts Receivable, 5 Yr. CAGR %	16.27	13.56	14.67	10.44	2.39
Inventory, 5 Yr. CAGR %	36.65	32.18	29.12	19.41	13.02
Net Property, Plant and Equip., 5 Yr. CAGR %	22.7	30.94	37.56	32.21	22.38
Total Assets, 5 Yr. CAGR %	24.82	25.37	26.49	14.37	10.58
Tangible Book Value, 5 Yr. CAGR %	27.71	22.75	19.37	5.58	4.09
Common Equity, 5 Yr. CAGR %	27.29	22.8	19.59	6.24	4.15
Cash From Operations, 5 Yr. CAGR %	37.93	16.96	8.54	1.66	6.9
Capital Expenditures, 5 Yr. CAGR %	31.2	42.59	47.23	8.64	-19.48
Levered Free Cash Flow, 5 Yr. CAGR %	46.37	85.43	76.87	34.96	4.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	48.3	96.7	96.42	34.66	6.6
Dividend Per Share, 5 Yr. CAGR %	-	-	3.19	-1.87	-7.36